103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB3873 Introduced , by Rep. Jackie Haas SYNOPSIS AS INTRODUCED: 720 ILCS 570/206 from Ch. 56 1/2, par. 1206 Amends the Illinois Controlled Substances Act. Schedules Xylazine: (N-2,6-dimethylpheny1)-5,6-dihydro-4H-1,3 thiazin-2-amine), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation as a Schedule II controlled substance. LRB103 31050 RLC 57668 b A BILL FOR 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB3873 Introduced , by Rep. Jackie Haas SYNOPSIS AS INTRODUCED: 720 ILCS 570/206 from Ch. 56 1/2, par. 1206 720 ILCS 570/206 from Ch. 56 1/2, par. 1206 Amends the Illinois Controlled Substances Act. Schedules Xylazine: (N-2,6-dimethylpheny1)-5,6-dihydro-4H-1,3 thiazin-2-amine), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation as a Schedule II controlled substance. LRB103 31050 RLC 57668 b LRB103 31050 RLC 57668 b A BILL FOR
103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB3873 Introduced , by Rep. Jackie Haas SYNOPSIS AS INTRODUCED:
720 ILCS 570/206 from Ch. 56 1/2, par. 1206 720 ILCS 570/206 from Ch. 56 1/2, par. 1206
720 ILCS 570/206 from Ch. 56 1/2, par. 1206
Amends the Illinois Controlled Substances Act. Schedules Xylazine: (N-2,6-dimethylpheny1)-5,6-dihydro-4H-1,3 thiazin-2-amine), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation as a Schedule II controlled substance.
LRB103 31050 RLC 57668 b LRB103 31050 RLC 57668 b
LRB103 31050 RLC 57668 b
A BILL FOR
HB3873LRB103 31050 RLC 57668 b HB3873 LRB103 31050 RLC 57668 b
HB3873 LRB103 31050 RLC 57668 b
1 AN ACT concerning criminal law.
2 Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
4 Section 5. The Illinois Controlled Substances Act is
5 amended by changing Section 206 as follows:
6 (720 ILCS 570/206) (from Ch. 56 1/2, par. 1206)
7 Sec. 206. (a) The controlled substances listed in this
8 Section are included in Schedule II.
9 (b) Unless specifically excepted or unless listed in
10 another schedule, any of the following substances whether
11 produced directly or indirectly by extraction from substances
12 of vegetable origin, or independently by means of chemical
13 synthesis, or by combination of extraction and chemical
14 synthesis:
15 (1) Opium and opiates, and any salt, compound,
16 derivative or preparation of opium or opiate, excluding
17 apomorphine, dextrorphan, levopropoxyphene, nalbuphine,
18 nalmefene, naloxone, and naltrexone, and their respective
19 salts, but including the following:
20 (i) Raw Opium;
21 (ii) Opium extracts;
22 (iii) Opium fluid extracts;
23 (iv) Powdered opium;
103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB3873 Introduced , by Rep. Jackie Haas SYNOPSIS AS INTRODUCED:
720 ILCS 570/206 from Ch. 56 1/2, par. 1206 720 ILCS 570/206 from Ch. 56 1/2, par. 1206
720 ILCS 570/206 from Ch. 56 1/2, par. 1206
Amends the Illinois Controlled Substances Act. Schedules Xylazine: (N-2,6-dimethylpheny1)-5,6-dihydro-4H-1,3 thiazin-2-amine), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation as a Schedule II controlled substance.
LRB103 31050 RLC 57668 b LRB103 31050 RLC 57668 b
LRB103 31050 RLC 57668 b
A BILL FOR
720 ILCS 570/206 from Ch. 56 1/2, par. 1206
LRB103 31050 RLC 57668 b
HB3873 LRB103 31050 RLC 57668 b
HB3873- 2 -LRB103 31050 RLC 57668 b HB3873 - 2 - LRB103 31050 RLC 57668 b
HB3873 - 2 - LRB103 31050 RLC 57668 b
1 (v) Granulated opium;
2 (vi) Tincture of opium;
3 (vii) Codeine;
4 (viii) Ethylmorphine;
5 (ix) Etorphine Hydrochloride;
6 (x) Hydrocodone;
7 (xi) Hydromorphone;
8 (xii) Metopon;
9 (xiii) Morphine;
10 (xiii.5) 6-Monoacetylmorphine;
11 (xiv) Oxycodone;
12 (xv) Oxymorphone;
13 (xv.5) Tapentadol;
14 (xvi) Thebaine;
15 (xvii) Thebaine-derived butorphanol.
16 (xviii) Methorphan, except drug products
17 containing dextromethorphan that may be dispensed
18 pursuant to a prescription order of a practitioner and
19 are sold in compliance with the safety and labeling
20 standards as set forth by the United States Food and
21 Drug Administration, or drug products containing
22 dextromethorphan that are sold in solid, tablet,
23 liquid, capsule, powder, thin film, or gel form and
24 which are formulated, packaged, and sold in dosages
25 and concentrations for use as an over-the-counter drug
26 product. For the purposes of this Section,
HB3873 - 2 - LRB103 31050 RLC 57668 b
HB3873- 3 -LRB103 31050 RLC 57668 b HB3873 - 3 - LRB103 31050 RLC 57668 b
HB3873 - 3 - LRB103 31050 RLC 57668 b
1 "over-the-counter drug product" means a drug that is
2 available to consumers without a prescription and sold
3 in compliance with the safety and labeling standards
4 as set forth by the United States Food and Drug
5 Administration.
6 (2) Any salt, compound, isomer, derivative or
7 preparation thereof which is chemically equivalent or
8 identical with any of the substances referred to in
9 subparagraph (1), but not including the isoquinoline
10 alkaloids of opium;
11 (3) Opium poppy and poppy straw;
12 (4) Coca leaves and any salt, compound, isomer, salt
13 of an isomer, derivative, or preparation of coca leaves
14 including cocaine or ecgonine, and any salt, compound,
15 isomer, derivative, or preparation thereof which is
16 chemically equivalent or identical with any of these
17 substances, but not including decocainized coca leaves or
18 extractions of coca leaves which do not contain cocaine or
19 ecgonine (for the purpose of this paragraph, the term
20 "isomer" includes optical, positional and geometric
21 isomers);
22 (5) Concentrate of poppy straw (the crude extract of
23 poppy straw in either liquid, solid or powder form which
24 contains the phenanthrine alkaloids of the opium poppy).
25 (c) Unless specifically excepted or unless listed in
26 another schedule any of the following opiates, including their
HB3873 - 3 - LRB103 31050 RLC 57668 b
HB3873- 4 -LRB103 31050 RLC 57668 b HB3873 - 4 - LRB103 31050 RLC 57668 b
HB3873 - 4 - LRB103 31050 RLC 57668 b
1 isomers, esters, ethers, salts, and salts of isomers, whenever
2 the existence of these isomers, esters, ethers and salts is
3 possible within the specific chemical designation, dextrorphan
4 excepted:
5 (1) Alfentanil;
6 (1.1) Carfentanil;
7 (1.2) Thiafentanyl;
8 (2) Alphaprodine;
9 (3) Anileridine;
10 (4) Bezitramide;
11 (5) Bulk Dextropropoxyphene (non-dosage forms);
12 (6) Dihydrocodeine;
13 (7) Diphenoxylate;
14 (8) Fentanyl;
15 (8.5) Xylazine: (N-2,6-dimethylpheny1)-5,6-
16 dihydro-4H-1,3 thiazin-2-amine), including its isomers,
17 esters, ethers, salts, and salts of isomers, esters, and
18 ethers, whenever the existence of such isomers, esters,
19 ethers, and salts is possible within the specific chemical
20 designation;
21 (9) Sufentanil;
22 (9.5) Remifentanil;
23 (10) Isomethadone;
24 (11) (Blank);
25 (12) Levorphanol (Levorphan);
26 (13) Metazocine;
HB3873 - 4 - LRB103 31050 RLC 57668 b
HB3873- 5 -LRB103 31050 RLC 57668 b HB3873 - 5 - LRB103 31050 RLC 57668 b
HB3873 - 5 - LRB103 31050 RLC 57668 b
1 (14) Methadone;
2 (15) Methadone-Intermediate,
3 4-cyano-2-dimethylamino-4,4-diphenyl-1-butane;
4 (16) Moramide-Intermediate,
5 2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic
6 acid;
7 (17) Pethidine (meperidine);
8 (18) Pethidine-Intermediate-A,
9 4-cyano-1-methyl-4-phenylpiperidine;
10 (19) Pethidine-Intermediate-B,
11 ethyl-4-phenylpiperidine-4-carboxylate;
12 (20) Pethidine-Intermediate-C,
13 1-methyl-4-phenylpiperidine-4-carboxylic acid;
14 (21) Phenazocine;
15 (22) Piminodine;
16 (23) Racemethorphan;
17 (24) (Blank);
18 (25) Levo-alphacetylmethadol (some other names:
19 levo-alpha-acetylmethadol, levomethadyl acetate, LAAM).
20 (d) Unless specifically excepted or unless listed in
21 another schedule, any material, compound, mixture, or
22 preparation which contains any quantity of the following
23 substances having a stimulant effect on the central nervous
24 system:
25 (1) Amphetamine, its salts, optical isomers, and salts
26 of its optical isomers;
HB3873 - 5 - LRB103 31050 RLC 57668 b
HB3873- 6 -LRB103 31050 RLC 57668 b HB3873 - 6 - LRB103 31050 RLC 57668 b
HB3873 - 6 - LRB103 31050 RLC 57668 b
1 (2) Methamphetamine, its salts, isomers, and salts of
2 its isomers;
3 (3) Phenmetrazine and its salts;
4 (4) Methylphenidate;
5 (5) Lisdexamfetamine.
6 (e) Unless specifically excepted or unless listed in
7 another schedule, any material, compound, mixture, or
8 preparation which contains any quantity of the following
9 substances having a depressant effect on the central nervous
10 system, including its salts, isomers, and salts of isomers
11 whenever the existence of such salts, isomers, and salts of
12 isomers is possible within the specific chemical designation:
13 (1) Amobarbital;
14 (2) Secobarbital;
15 (3) Pentobarbital;
16 (4) Pentazocine;
17 (5) Phencyclidine;
18 (6) Gluthethimide;
19 (7) (Blank).
20 (f) Unless specifically excepted or unless listed in
21 another schedule, any material, compound, mixture, or
22 preparation which contains any quantity of the following
23 substances:
24 (1) Immediate precursor to amphetamine and
25 methamphetamine:
26 (i) Phenylacetone
HB3873 - 6 - LRB103 31050 RLC 57668 b
HB3873- 7 -LRB103 31050 RLC 57668 b HB3873 - 7 - LRB103 31050 RLC 57668 b
HB3873 - 7 - LRB103 31050 RLC 57668 b
1 Some trade or other names: phenyl-2-propanone;
2 P2P; benzyl methyl ketone; methyl benzyl ketone.
3 (2) Immediate precursors to phencyclidine:
4 (i) 1-phenylcyclohexylamine;
5 (ii) 1-piperidinocyclohexanecarbonitrile (PCC).
6 (3) Nabilone.
7 (Source: P.A. 100-368, eff. 1-1-18.)
HB3873 - 7 - LRB103 31050 RLC 57668 b